News

News

  • 2023-04-20
    Vitiligo is a skin condition that affects up to 1.11% of the US population, causing loss of skin color and creating white patches on the skin. It can be especially upsetting when it affects the face, where it's more noticeable. Until recently, tre...
  • 2023-04-18
    The official logo for World Vitiligo Day (WVD) 2023, to be held in Kazakhstan, has been unveiled. This logo was crafted by local artist Zhanar Sagidolla, who emerged as the winner in the logo design contest. The competition was overseen by the WVD...
  • 2023-04-12
    Can you imagine waking up one day to find that the person in the mirror no longer resembles the one you've always known? For Valarie Molyneaux, this was her reality when she was diagnosed with vitiligo - a condition that causes the skin to lose it...
  • 2023-04-10
    Calling all vitiligo patients in the Tristate area! Liz Lewis Casting Partners and SELF by Conde Nast are collaborating on a project that highlights and educates on the impact of vitiligo. We are currently looking for individuals to share their pe...
  • 2023-04-03
    Today we celebrate the outstanding achievement of Prof. Torello Lotti, the esteemed Chair of the Scientific Board of Vitiligo Research Foundation. The Italian Republic has recognized his exceptional contributions to academia by awarding him the di...
  • 2023-03-30
    Mark your calendars and pack your sunscreen! On June 25th, 2023, a brilliant beacon will shine on vitiligo as the thirteenth annual World Vitiligo Day (WVD) unfolds in Almaty, Kazakhstan. This vibrant global event unites researchers, doctors, and...
  • 2023-03-22
    A recent study presented at the GVF Annual Scientific Symposium in New Orleans has shown promising results in treating vitiligo. Led by Dr. Ammar Ahmed from the University of Texas at Austin Dell Medical School, the study utilized TruPigment™ by T...
  • 2023-03-20
    Biopharmaceutical company Incyte has recently revealed promising results from a clinical trial focusing on the safety and efficacy of povorcitinib in adult patients with extensive vitiligo. The findings were presented at the American Academy of De...
  • 2023-03-18
    Incyte unveiled intriguing 104-week results from its pivotal Phase 3 TRuE-V clinical trial program, which assessed Opzelura® (ruxolitinib) cream 1.5% in nonsegmental vitiligo patients aged 12 and older. These findings, presented at the 2023 Americ...
  • 2023-02-25
    Boost your weekend mood with some good news:   The European Medicines Agency expressed a positive opinion on Opzelura earlier this week. The green light opens the fast track for it to become the first ‘official’ vitiligo therapy in the EU. Incyte...
  • 2023-02-24
    Great news for the vitiligo community in the EU! Incyte has just announced in a press-release that ruxolitinib cream (Opzelura™) has received a positive opinion from the European Medicines Agency (EMA) committee for the treatment of vitiligo with...
  • 2023-02-22
    Vitiligo is a complex and puzzling autoimmune disorder that causes the loss of pigment-producing cells called melanocytes, leading to white patches on the skin. While the exact cause of vitiligo remains unknown, researchers believe both genetic an...
  • 2023-02-16
    VYNE Therapeutics Inc. recently announced positive results from the Phase 1a portion of its Phase 1a/b clinical trial evaluating its novel BET inhibitor, VYN201, for vitiligo. This drug candidate is a locally administered, small molecule, pan-bro...
  • 2023-02-14
    Just before the Valentine's Day, our Instagram community expressed their ambitions for this year. Amongst the variety of goals shared, two themes emerged - to 'experience something new' and to 'eliminate white spots'.  Here are highlights from ou...
  • 2023-02-08
    In this newsletter, we discuss the latest research, current treatments, and potential developments in the field. Examine the correlations between the incidence of vitiligo and the chemical variables that influence the condition. Read the latest cl...
  • 2023-02-06
    Clinical trials are experiments that test how well new drugs, treatments or devices work in people. Trials progress through Phases I-IV to test a drug candidate, find the appropriate dosage, and look for side effects. The goal is to determine whet...
  • 2023-01-31
    Are you an Adult or Adolescent (age 12 – 17) with nonsegmental vitiligo? Nonsegmental means vitiligo on both sides of your body. If so, you may qualify to take part in a non-treatment research interview study asking you about your experiences wit...
  • 2023-01-27
    Research and treatments for vitiligo have seen a significant increase in recent years, offering new possibilities.  The treatment options for vitiligo are rapidly expanding, with the first Food and Drug Administration-approved treatment leading t...
  • 2023-01-24
    Sharing a nationwide call for teens 12-18 and adults 55-70 years old of any ethnicity with the most common, generalized form of vitiligo. Shoots in NYC next week (travel provided). Pays $1k/shoot + $2k buyout. To respond, please fill out this f...
  • 2023-01-16
    Actress, singer and producer Mamta Mohandas revealed that she is suffering from vitiligo, - on Instagram with a picture of herself and a poem: "Dear Sun ☀️, I embrace you now like I have never before. So Spotted, I’m losing colour… I rise e...
  • 2023-01-10
    Meet 22-year-old Tanya Manhenga, — one of contestants of a hit dating TV show “Love Island.”  Manhenga is one of the ten Islanders who will be in South Africa for six weeks looking for love in the new villa. Love Island UK, winter season 2023, ki...
  • 2023-01-04
    Pune-based startup Ahammune Biosciences has recently completed the phase 1 clinical trials of its investigational new drug AB1001, being developed as a topical therapy for vitiligo.  Dr T. Balganesh, Chairman of Ahammune’s Board said, “Vitiligo i...
  • 2023-01-03
    While 2022 didn't unfold as any of us had hoped, we are grateful for what we accomplished with your support as we look back. The Vitiligo Research Foundation (VRF) has made a notable mark on the world-wide vitiligo community, from providing educat...
  • 2022-12-12
    New research suggests that exposure to phenols and catechols raising the risk of vitiligo onset by 4 times. The study conducted at the University of Sfax in Tunisia indicated the following risk factors for vitiligo: household chemical use hair...
  • 2022-11-14
    Researchers from Northwestern University are conducting a research survey on the use of natural remedies, supplements and camouflage by vitiligo patients, so that dermatologists can provide them with more competent and relevant care. Investigat...